| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $54.2M | +20.6% |
| SG&A Expense | $16.1M | +50.6% |
| Operating Income | -$70.4M | -26.4% |
| Income Tax | $1K | -50.0% |
| Net Income | -$68.9M | -25.2% |
| EPS (Basic) | -$0.90 | -26.8% |
| EPS (Diluted) | -$0.90 | -26.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.6M | +38.9% |
| Current Assets | $167.0M | -20.7% |
| Total Assets | $168.5M | -20.0% |
| Current Liabilities | $21.9M | +150.0% |
| Total Liabilities | $23.2M | +164.4% |
| Stockholders' Equity | $145.3M | -28.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.4M | -1.7% |
| Investing Cash Flow | $54.8M | +44.2% |
| Financing Cash Flow | $4.2M | -39.5% |